Aureomycin 50 Granular A

This page contains information on Aureomycin 50 Granular A for veterinary use.
The information provided typically includes the following:
  • Aureomycin 50 Granular A Indications
  • Warnings and cautions for Aureomycin 50 Granular A
  • Direction and dosage information for Aureomycin 50 Granular A

Aureomycin 50 Granular A

This treatment applies to the following species:
Manufacturer: Zoetis

GUARANTEED AUREOMYCIN® CHLORTETRACYCLINE

Chlortetracycline

Type A Medicated Article

Active Drug Ingredient

Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.

Ingredients

Aureomycin Granular Type A Medicated Article (Dried Streptomyces aureofaciens Fermentation Product and Calcium Sulfate) and Calcium Carbonate.

For use in the manufacture of medicated animal feeds.

For use in dry feed only. Not for use in liquid medicated feeds.

Use Directions

Mix sufficient Aureomycin 50 Granular A Medicated Article to supply desired concentration of chlortetracycline per ton with part of the feed ingredients to make a preblend.

Add the remainder of the ingredients and mix thoroughly. For specific use levels, see Indications.

Mixing directions

Level desired grams per ton

Amount of medicated article per ton

10

1/5 lb

50

1 lb

100

2 lb

200

4 lb

400

8 lb

500

10 lb

It is recommended that 1 pound of Aureomycin 50 Granular A Type A Medicated Article be diluted with 4 pounds of one of the feed ingredients to form a 5 pound working premix. Use 1 pound of the working premix to make a preblend (see Use directions) for a Type C feed containing 10 g Aureomycin chlortetracycline / ton of feed.

Aureomycin 50 Granular A Indications

Chlortetracycline mg per lb body wt per day

Cattle

Calves (up to 250 lb): Increased rate of weight gain and improved feed efficiency.

0.1

Beef Cattle (over 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.

0.5

Beef and Non-Lactating Dairy Cattle: As an aid in control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline when delivered in a free-choice feed. Free-choice feed must be manufactured under a feed mill license utilizing an FDA approved formulation.

0.5-2.0

Calves, Beef and Non-Lactating Dairy Cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. Feed for not more than 5 days. The appropriate amount of Aureomycin-containing feed supplement may be mixed in the cattle’s daily ration or administered as a top-dress. If the Aureomycin-containing feed supplement is administered as a top-dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time.

10

Swine

Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline.

Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.

(Note: this drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight.)

Feed for not more than 14 days.

10

Turkeys

Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis; coronaviral enteritis) susceptible to chlortetracycline. Feed continuously for 7 to 14 days.

25


Aureomycin 50 Granular A Indications

mg per head per day

Cattle

Calves (250 to 400 lb): Increased rate of weight gain and improved feed efficiency.

25-70

Growing Cattle (over 400 lb): Increased rate of weight gain, improved feed efficiency, and reduction of liver condemnation due to liver abscesses.

70

Beef Cattle: Control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.

350

Beef Cattle (under 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.

350

Sheep

Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline.

80


Aureomycin 50 Granular A Indications

In complete feed Chlortetracycline g per ton

Swine

Increased rate of weight gain and improved feed efficiency.

10-50

Reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline.

50-100

Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. Feed continuously for not more than 14 days.

400

Sheep

Increased rate of weight gain and improved feed efficiency.

20-50

Ducks

Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline. Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending upon age and severity of disease. Feed for not more than 21 days.

200-400

Chickens

Increased rate of weight gain and improved feed efficiency.

10-50

Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.

Feed continuously for 7 to 14 days.

100-200

Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline.

Feed continuously for 7 to 14 days.

200-400

Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline. Feed for 5 days.

500

Turkeys

Increased rate of weight gain and improved feed efficiency.

10-50

Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.

Feed continuously for 7 to 14 days.

200

Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline.

Feed continuously for 7 to 14 days.

400

Turkey Poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline.

400


Aureomycin 50 Granular A Indications

mg per g feed

Psittacine birds

Warning: Psittacosis, avian chlamydiosis, or ornithosis is a reportable communicable disease, transmissible between wild and domestic birds, other animals and man. Contact appropriate public health and regulatory officials.

Aureomycin 50 Granular A Caution

Aspergilliosis may occur following prolonged treatment.

 

Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline. Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of its body weight daily. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.

10


Warning

A withdrawal period has not been established for this product in pre-ruminating calves.

Do not use in calves to be processed for veal.

Do not feed to ducks or turkeys producing eggs for human consumption.

NADA 48-761, Approved by FDA

Trademarks registered by Alpharma, LLC

Marketed by Alpharma, LLC, Bridgewater, New Jersey 08807

Net wt

 

10 LB (4.54 kg)

700617 0812

50 LB (22.68 kg)

700609 1005

NAC No.: 10221451

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-833-4000
Customer Service:   800-733-5500 and 800-793-0596
Veterinary Medical Investigations & Product Support:   800-366-5288
Technical Services (USA):   800-366-5288
Website:   www.zoetis.com
Every effort has been made to ensure the accuracy of the Aureomycin 50 Granular A information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web2)